Paul Kelly - Sep 9, 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role: Director
Signature: /s/ Paul Kelly
Stock symbol: RLMD
Transactions as of: Sep 9, 2024
Transactions value $: $64,750
Form type: 4
Date filed: 9/11/2024, 05:46 PM
Previous filing: May 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLMD	Common Stock	Purchase	$64.8K	+25K	+13.35%	$2.59	212K	Sep 9, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2	Purchase prices range from $2.50 to $2.64 per share, inclusive.

Content

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Purchase prices range from $2.50 to $2.64 per share, inclusive.